Esprinet Statistics

Total Valuation

Esprinet has a market cap or net worth of GBP 211.89 million. The enterprise value is 251.53 million.

Market Cap	211.89M
Enterprise Value	251.53M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	May 5, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.71%
Shares Change (QoQ)	-1.90%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	27.84M

Valuation Ratios

The trailing PE ratio is 11.91.

PE Ratio	11.91
Forward PE	n/a
PS Ratio	0.06
PB Ratio	0.66
P/TBV Ratio	0.97
P/FCF Ratio	n/a
P/OCF Ratio	92.34
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.26, with an EV/FCF ratio of -94.96.

EV / Earnings	14.13
EV / Sales	0.07
EV / EBITDA	4.26
EV / EBIT	6.41
EV / FCF	-94.96

Financial Position

The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.68.

Current Ratio	1.21
Quick Ratio	0.76
Debt / Equity	0.68
Debt / EBITDA	3.79
Debt / FCF	-82.07
Interest Coverage	2.94

Financial Efficiency

Return on equity (ROE) is 5.69% and return on invested capital (ROIC) is 4.52%.

Return on Equity (ROE)	5.69%
Return on Assets (ROA)	1.49%
Return on Invested Capital (ROIC)	4.52%
Return on Capital Employed (ROCE)	7.74%
Revenue Per Employee	1.89M
Profits Per Employee	9,844
Employee Count	1,808
Asset Turnover	2.15
Inventory Turnover	6.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.26% in the last 52 weeks. The beta is 1.28, so Esprinet's price volatility has been higher than the market average.

Beta (5Y)	1.28
52-Week Price Change	-1.26%
50-Day Moving Average	4.70
200-Day Moving Average	5.02
Relative Strength Index (RSI)	61.94
Average Volume (20 Days)	426

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Esprinet had revenue of GBP 3.42 billion and earned 17.80 million in profits. Earnings per share was 0.36.

Revenue	3.42B
Gross Profit	187.67M
Operating Income	38.09M
Pretax Income	23.87M
Net Income	17.80M
EBITDA	45.81M
EBIT	38.09M
Earnings Per Share (EPS)	0.36

Full Income Statement

Balance Sheet

The company has 178.92 million in cash and 217.39 million in debt, giving a net cash position of -38.47 million.

Cash & Cash Equivalents	178.92M
Total Debt	217.39M
Net Cash	-38.47M
Net Cash Per Share	n/a
Equity (Book Value)	321.90M
Book Value Per Share	6.51
Working Capital	242.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.29 million and capital expenditures -4.94 million, giving a free cash flow of -2.65 million.

Operating Cash Flow	2.29M
Capital Expenditures	-4.94M
Free Cash Flow	-2.65M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 5.48%, with operating and profit margins of 1.11% and 0.52%.

Gross Margin	5.48%
Operating Margin	1.11%
Pretax Margin	0.70%
Profit Margin	0.52%
EBITDA Margin	1.34%
EBIT Margin	1.11%
FCF Margin	n/a

Dividends & Yields

Esprinet does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.71%
Shareholder Yield	-0.71%
Earnings Yield	8.40%
FCF Yield	-1.25%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Esprinet has an Altman Z-Score of 2.41. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.41
Piotroski F-Score	n/a